Wipfli Financial Advisors Llc, Vir Biotechnology, Inc. Transaction History
Wipfli Financial Advisors Llc,
- $1.42 Billion
- Q3 2022
A detailed history of Wipfli Financial Advisors Llc, transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Wipfli Financial Advisors Llc, holds 1,315 shares of VIR stock, worth $5,733. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,315Holding current value
$5,733% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VIR
# of Institutions
255Shares Held
94.9MCall Options Held
257KPut Options Held
261K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$72.7 Million0.99% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$71.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$57.7 Million0.0% of portfolio
-
State Street Corp Boston, MA5.73MShares$25 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$13.1 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $578M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...